The use of a novel transrectal “finger-probe” allows to do the BIA test with a minimal discomfort for the patient, contributing to an accuracy as high as 75% for the PCa vs. BPH prediction when properly combined with BMI, total PSA, and PSA density. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.